Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Cytiva, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, LabVantage. Biologics Manufacturing Cytiva in $31-M US Gov’t Pact for Consumables for COVID Vaccines...

Thermo Fisher Scientific has announced plans to invest $130 million for a new sterile manufacturing facility in Singapore. The new facility will initially include a high-speed sterile line approved for live virus filling and an additional line for...

Abzena, a contract manufacturer of biologics and antibody drug conjugates, has invested $60 million in a new facility in San Diego, California for late-phase and commercial manufacturing. The new facility is approximately 50,000 square feet and...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Rentschler Biopharma, Fujifilm, Cobra Biologics, Recipharm, and Kindred Biosciences. Biologics Manufacturing Rentschler Biopharma, BioNTech in COVID-19 Mfg Vaccine...

Sartorius, a provider of products and services for the life sciences, has agreed to acquire BIA Separations, an Ajdovščina, Slovenia-headquartered developer and manufacturer of purification products, for EUR 360 million ($423 million). BIA...

Sterling Pharma Solutions, a Dudley, UK-based CDMO of small-molecule active pharmaceutical ingredients (APIs) and intermediates, has acquired a small-molecule API manufacturing facility in Germantown, Wisconsin from Alcami, a CDMO of APIs and drug...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Thermo Fisher Scientific and Hovione. Biologics Manufacturing Thermo Fisher, Humanigen in Mfg Pact for COVID-19 mAb CandidateThermo Fisher Scientific and Humanigen, a...

The latest from CDMOs, CMOs, and suppliers featuring Piramal Pharma Solutions, Catalent, Metrics Contract Services, Aphena, Vetter, and BioLife. Biologics Manufacturing BioLife Solutions To Acquire SciSafe for $30 MBioLife Solutions, a Bothell,...

AstraZeneca and Samsung Biologics, an Incheon, South Korea-based contract biologics manufacturer, have entered into a long-term supply agreement, valued at approximately $330.8 million, to support AstraZeneca’s biologics therapeutics. Under the...